Commission Implementing Decision (EU) 2025/1791 of 10 September 2025 postponing the expiry date of the approval of imidacloprid for use in biocidal products of product-type 18 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council
Text
Article-level text, parsed from the formex manifestation.
Article 1
The expiry date of the approval of imidacloprid for use in biocidal products of product-type 18 set out in Implementing Decision (EU) 2023/460 is postponed to 31 December 2027.
Article 2
This Decision shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.
Relations
What this act cites, and what cites it.
Show relationsVersions
Point-in-time consolidated versions of this act.
Show versions